Analysis of AI-based medical innovation companies
Between 2024 and 2025, a number of innovative technologies will emerge in the medical and bio fields, bringing about major changes to the industry.
especially AI-based new drug development, nanotechnology-based therapeutics, digital healthcare platforms, and other technologies are taking the lead, and these technologies have the potential to dramatically change the existing medical environment and treatment methods.
AIBig data and deep learning technologies are now influencing not only simple research and development but also actual clinical treatment, rapidly increasing the speed and efficiency of new drug development. Additionally, nanotechnology enables precise delivery of therapeutics and effective disease targeting, giving birth to next-generation treatments that go beyond existing treatments.
Innovations like these are making the future of healthcare brighter and more hopeful by enabling more personalized, tailored treatment for patients.
This article introduces some notable companies that have started operations based on these innovative technologies.
Notable domestic innovative companies
Renime
Year of Establishment: 2024
Key technologies: Development of mRNA-based therapeutics using cationic liposome technology
Main Products: Osteoarthritis treatment, pancreatic cancer vaccine
characteristic: We are developing therapeutics that effectively deliver mRNA into cells using cationic liposome technology.
MDmun
Year of Establishment: 2024
Key technologies: Development of AI-based human cell-derived nanovesicle-based drug delivery system
characteristic: We aim to deliver drugs more safely and effectively than conventional LNP technology through a nanovesicle-based drug delivery system.
Senix Biotech
Year of Establishment: 2024
Key technologies: Development of nanomaterials with maximized enzyme function
characteristic: We are developing enzyme-based therapeutics that remove malignant reactive oxygen species.
Imaginon Biosystems
Year of Establishment: 2024
Key technologies: Development of an early diagnosis platform for pancreatic cancer using AI-based nano-image discovery technology
characteristic: We are developing a platform for early diagnosis of pancreatic cancer and are collaborating with Prestige Biopharma.
Notable overseas innovative companies
Moderna (USA)
Year of Establishment: 2010 (but continues to innovate in 2024-2025)
Key technologies: Development of mRNA-based vaccines and therapeutics
characteristic: As a company that developed a COVID-19 vaccine, we are developing new drugs and treatments for various diseases based on mRNA technology.
BioNTech (Germany)
Year of Establishment: 2008
Key technologies: mRNA vaccine development
characteristic: After working with Pfizer to develop a COVID-19 vaccine, BioNTech is developing a range of treatments using mRNA technology.
CRISPR Therapeutics (USA)
Year of Establishment: 2013
Key technologies: CRISPR-Cas9 gene editing technology
characteristic: Various genetic qualities based on gene editing technology
We are developing a treatment for cancer, and this technology is revolutionizing the medical field.
NVIDIA (USA)
Year of Establishment: 1993
Key technologies: AI-based New drug development platform 'BioNeMO'
characteristic: Nvidia is AI and GPU hardware to participate in new drug development
We are currently supporting protein design and multiple therapeutic protein design through the BioNeMO platform.
Illumina (USA)
Year of Establishment: 1998
Key technologies: Genetic Analysis and DNA Sequencing Technologies
characteristic: Genetic analysis and DNA sequencing technologies are making great strides in personalized medicine and gene therapy.
When divided this way, domestic startups are mainly participating in the medical and bio industries with a focus on innovative technologies, while overseas companies are already global leaders with a strong foundation.
Each company AI, mRNA, gene editing, and other cutting-edge technologies are being used to lead the development of new drugs and innovation in treatment.
mRNA (messenger RNA) supplementary information
mRNA (messenger RNA) is a molecule that plays an important role in helping the process of making proteins within cells. mRNA acts as a “messenger” that carries genetic information, transferring genetic information stored in DNA to the cell’s ribosomes, which then synthesize proteins based on this information.
The basic process of mRNA:
Gene Transcription: mRNA is made from DNA. This process takes place in the cell nucleus.
Protein Translation: The generated mRNA moves to the cytoplasm and binds to ribosomes, and the ribosomes read the information in the mRNA and synthesize the corresponding protein.
The importance of mRNA
mRNA plays a vital role in helping cells make the proteins they need, which is essential for maintaining normal functioning of our bodies.
It is also used in vaccines. For example, mRNA vaccines deliver information in the form of mRNA to cells to make specific proteins, thereby inducing an immune response. The COVID-19 vaccine is a representative example.
Therefore, mRNA plays a key role in transmitting important information within cells and maintaining healthy function.
Three line summary
-
In the medical and bio fields between 2024 and 2025, new drug development and customized treatment using AI, mRNA, and nanotechnology are rapidly developing.
-
Domestic and international innovative companies are leading medical innovation with cutting-edge technologies such as AI-based drug delivery, gene editing, and early diagnosis platforms.
-
mRNA technology plays a key role in protein production and has become an important foundational technology in the development of vaccines and therapeutics.
*Promising Korean AI startups Go see
EN 
KO